+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Idebenone"

Leber's Hereditary Optic Neuropathy - Pipeline Insight, 2024 - Product Thumbnail Image

Leber's Hereditary Optic Neuropathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Idebenone - Drug Insight and Market Forecast - 2030 - Product Thumbnail Image

Idebenone - Drug Insight and Market Forecast - 2030

  • Report
  • August 2020
  • 80 Pages
  • Global
From
From
  • 6 Results (Page 1 of 1)
Loading Indicator

Idebenone is a synthetic compound used in the treatment of central nervous system (CNS) disorders. It is a short-chain benzoquinone derivative that acts as an antioxidant and free radical scavenger. Idebenone is used to treat a variety of CNS disorders, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS). It is also used to treat mitochondrial diseases, such as Leigh syndrome, and to improve cognitive function in patients with dementia. Idebenone has been found to be effective in reducing the symptoms of these diseases, as well as improving cognitive function. Idebenone is available in both oral and intravenous formulations. It is generally well tolerated, with few side effects. The most common side effects include nausea, vomiting, and diarrhea. Idebenone is marketed by several companies, including Eisai, Merz Pharmaceuticals, and Teva Pharmaceuticals. It is also available as a generic drug. Show Less Read more